Thyrotropin receptor-associated diseases: From adenomata to Graves disease

Journal of Clinical Investigation

Volumn 115, Issue 8, 2005, Pages 1972-1983

  Davies, Terry F ^a   Ando, Takao ^a   Lin, Reigh Yi ^a   Tomer, Yaron ^a   Latif, Rauf ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN RECEPTOR;

CONGENITAL HYPOTHYROIDISM; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION; THYROID ADENOMA; THYROID NODULE;

ANIMALS; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, THYROTROPIN; THYROID GLAND;

EID: 23644456322     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI26031     Document Type: Review

References (125)

1. Davies, T.F., Marians, R., and Latif, R. 2002. The TSH receptor reveals itself. J. Clin. Invest. 110:161-164. doi:10.1172/JCI200216234.
2. Duprez, L., et al. 1999. Pathology of the TSH receptor. J. Pediatr. Endocrinol. Metab. 12(Suppl. 1):295-302.
3. Rapoport, B., Chazenbalk, G.D., Jaume, J.C., and McLachlan, S.M. 1998. The chyrotropin (TSH) receptor: interaction with TSH and autoantibodies [review]. Endocr. Rev. 19:673-716.
4. Kajita, Y., Rickards, C.R., Buckland, P.R., Howell, R.D., and Rees Smith, B. 1985. Analysis of thyrotropin receptors by photoaffinity labeling. Orientation of receptor subunits in the cell membrane. Biochem. J. 227:413-420.
5. Parmentier, M., et al. 1989. Molecular cloning of the thyrotropin receptor. Science. 246:1620-1622.
6. Libert, F., et al. 1989. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem. Biophys. Res. Commun. 165:1250-1255.
7. Nagayama, Y., Kaufman, K.D., Seto, P., and Rapoport, B. 1989. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem. Biophys. Res. Commun. 165:1250-1255.
8. Misrahi, M., et al. 1990. Cloning, sequencing and expression of human TSH receptor. Biochem. Biophys. Res. Commun. 166:394-403.
9. Libert, F., Passage, E., Lefort, A., Vassart, G., and Mattei, M.G. 1990. Localization of human thyrotropin receptor gene to chromosome region 14q3 by in situ hybridization. Cytogenet. Cell Genet. 54:82-83.
10. Loosfelt, H., et al. 1992. Two-subunit structure of the human thyrotropin receptor. Proc. Natl. Acad. Sci. U. S. A. 89:3765-3769.
11. Misrahi, M., et al. 1994. Processing of the precursors of the human thyroid-stimulating hormone receptor in various eukaryotic cells (human thyrocytes, transfected L cells and baculovirus-infected insect cells). Eur. J. Biochem. 222:711-719.
12. Shi, Y., Zou, M., Parhar, R.S., and Farid, N.R. 1993. High-affinity binding of thyrotropin to the extracellular domain of its receptor transfected in Chinese hamster ovary cells. Thyroid. 3:129-133.
13. Da Costa, C.R., and Johnstone, A.P. 1998. Production of the thyrotrophin receptor extracellular domain as a glycosylphosphatidylinositol-anchored membrane protein and its interaction with thyrotrophin and autoantibodies. J. Biol. Chem. 273:11874-11880.
14. Costagliola, S., Khoo, D., and Vassart, G. 1998. Production of bioactive amino-terminus domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor. FEBS Lett. 436:427-433.
15. Chazenbalk, G.D., Nagayama, Y., Russo, D., Wadsworth, H.L., and Rapoport, B. 1990. Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J. Biol. Chem. 265:20970-20975.
16. Vlaeminck-Guillem, V., Ho, S.C., Rodien, P., Vassart, G., and Costagliota, S. 2002. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol. Endocrinol. 16:736-746.
17. Wadsworth, H.L., Chazenbalk, G.D., Nagayama, V., Russo, D., and Rapoport, B. 1990. An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science. 249:1423-1425.
18. Chazenbalk, G.D., Tanaka, K., McLachlan, S.M., and Rapoport, B. 1999. On the functional importance of thyrotropin receptor intramolecular cleavage. Endocrinology. 140:4516-4520.
19. Wadsworth, H.L., Russo, D., Nagayama, Y., Chazenbalk, G.D., and Rapoport, B. 1992. Studies on the role of amino acids 38-45 in the expression of a functional thyrotropin receptor. Mol. Endocrinol. 6:394-398.
20. Chen, C.R., Tanaka, K., Chazenbalk, G.D., McLachlan, S.M., and Rapoport, B. 2001. A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor M terminus homologous to a laminin epidermal growth factor-like domain. J. Biol. Chem. 276:14767-14772.
21. Nagayama, Y., Russo, D., Wadsworth, H.L., Chazenbalk, G.D., and Rapoport, B. 1991. Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. J. Biol. Chem. 266:14926-14930.
22. Smits, G., et al. 2003. Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J. 22:2692-2703.
23. Nagayama, Y., Wadsworth, H.L., Russo, D., Chasenbalk, G.D., and Rapoport, B. 1991. Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. J. Clin. Invest. 88:336-340.
24. Jeffreys, J., et al. 2002. Characterization of the thyrotropin binding pocket. Thyroid. 12:1051-1061.
25. Chazenbalk, G.D., et al. 1997. Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology. 138:2893-2899.
26. Couet, J., et al. 1996. Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease. J. Biol. Chem. 271:4545-4552.
27. de Bernard, S., et al. 1999. Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain. J. Biol. Chem. 274:101-107.
28. Nunez Miguel, R.N., et al. 2004. Analysis of the TSH receptor-TSH interaction by comparative modeling. Thyroid. 14:991-1011.
29. Couet, J., et al. 1996. Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry. 35:14800-14805.
30. Tanaka, K., Chazenbalk, G.D., McLachlan, S.M., and Rapoport, B. 1999. Subunit structure of thyrotropin receptors expressed on the cell surface. J. Biol. Chem. 274:33979-33984.
31. Jordan, B.A., Trapaidze, N., Gomes, I., Nivatthi, R., and Devi, L.A. 2001. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc. Natl. Acad. Sci. U. S. A. 98:343-348.
32. Devi, L.A., and Brady, L.S. 2000. Dimerization of G-protein coupled receptors [review]. Neuropsychopharmacology. 23(4 Suppl.):S3-S4.
33. Trapaidze, N., Gomes, I., Cvejic, S., Bansinath, M., and Devi, L.A. 2000. Opioid receptor endocytosis and activation of MAP kinase pathway. Brain Res. Mol. Brain Res. 76:220-228.
34. Overton, M.C., and Blumer, K.J. 2000. G-protein-coupled receptors function as oligomers in vivo. Curr. Biol. 10:341-344.
35. Graves, P.N., Vlase, H., Bobovnikova, Y., and Davies, T.F. 1996. Multimeric complex formation by the thyrotropin receptor in solubilized thyroid membranes. Endocrinology. 137:3915-3920.
36. Latif, R., Graves, P., and Davies, T.F. 2001. Oligomerization of the human thyrotropin receptor: fluorescent protein-tagged hTSHR reveals post-translational complexes. J. Biol. Chem. 276:45217-45224.
37. Latif, R., Graves, P., and Davies, T.F. 2002. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J. Biol. Chem. 277:45059-45067.
38. Van Sande, J., et al. 1996. Specific activation of the thyrotropin receptor by trypsin. Mol. Cell. Endocrinol. 119:161-168.
39. Vassart, G., Pardo, L., and Costagliola, S. 2004. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem. Sci. 29:119-126.
40. Szkudlinski, M.W., Fremont, V., Ronin, C., and Weintraub, B.D. 2002. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol. Rev. 82:473-502.
41. Zhang, M., et al. 2000. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology. 141:3514-3517.
42. Brown, D.A., and London, E. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:111-136.
43. Simons, K., and Toomre, D. 2000. Lipid rafts and signal transduction [review]. Nat. Rev. Mol. Cell Biol. 1:31-39.
44. Latif, R., Ando, T., Daniel S., and Davies, T.F. 2003. Localization and regulation of thyrotropin receptors within lipid rafts. Endocrinology. 144:4725-4728.
45. Costa, M.J., et al. 2004. Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling. Endocrinology. 145:1464-1472.
46. Di Lauro, R., and De Felice, M. 2001. Thyroid gland: anatomy and development in endocrinology. 4th edition. L.J. DeGroot and J.L. Jameson, editors. WB Saunders Co. Philadelphia, Pennsylvania, USA. 1268-1277.
47. Van Vliet, G. 2003. Development of the thyroid gland: lessons from congenitally hypothyroid mice and men [review]. Clin. Genet. 63:445-455.
48. De Felice, M., et al. 1998. A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat. Genet. 19:395-398.
49. Brown, R.S. 2004. Minireview: developmental regulation of thyrotropin receptor gene expression in the fetal and newborn thyroid. Endocrinology. 145:4058-4061.
50. De Felice, M., Postiglione, M.P., and Di Lauro, R. 2004. Minireview: thyrotropin receptor signaling in development and differentiation of the thyroid gland: insights from mouse models and human diseases. Endocrinology. 145:4062-4067.
51. Postiglione, M.P., et al. 2002. Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc. Natl. Acad. Sci. U. S. A. 99:15462-15467.
52. Marians, R.C., et al. 2002. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc. Natl. Acad. Sci. U. S. A. 99:15776-15781.
53. Burrow, G.N., Fisher, D.A., and Larsen, P.R. 1994. Maternal and fetal thyroid function. N. Engl. J. Med. 331:1072-1078.
54. Bahn, R.S., et al. 1998. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 83:998-1002.
55. Daumerie, C., Ludgate, M., Costagliola, S., and Many, M.C. 2002. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur. J. Endocrinol. 146:35-38.
56. Vizek, K., Razova, M., and Melichar, V. 1979. Lipolytic effect of TSH, glucagon and hydrocortisone on the adipose tissue of newborns and adults in vitro. Physiol. Bohemoslov. 28:325-331.
57. Abe, E., et al. 2003. TSH is a negative regulator of skeletal remodeling. Cell. 115:151-162.
58. Refetoff, S. 2003. The syndrome of resistance to thyroid stimulating hormone. J. Chin. Med. Assoc. 66:441-452.
59. Alberti, L., et al. 2002. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 87:2549-2555.
60. Park, S.M., Clifton-Bligh, R.J., Betts, P., and Chatterjee, V.K. 2004. Congenital hypothyroidism and apparent athyreosis with compound heterozygosity or compensated hypothyroidism with probable hemizygosity for inactivating mutations of the TSH receptor. Clin. Endocrinol. (Oxf.). 60:220-227.
61. Fagman, H., Grande, M., Gritli-Linde, A., and Nilsson, M. 2004. Genetic deletion of sonic hedgehog causes hemiagenesis and ectopic development of the thyroid in mouse. Am. J. Pathol. 164:1865-1872.
62. Damante, G., Tell, G., and Di Lauro, R. 2001. A unique combination of transcription factors controls differentiation of thyroid cells. Prog. Nucleic Acid Res. Mol. Biol. 66:307-356.
63. Sunthornthepvarakui, T., Gottschalk, M.E., Hayashi, Y., and Refetoff, S. 1995. Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N. Engl. J. Med. 332:155-160.
64. Refetoff, S. 2003. Resistance to thyrotropin. J. Endocrinol. Invest. 26:770-779.
65. Abramowicz, M.J., Duprez, L., Parma, J., Vassart, G., and Heinrichs, C. 1997. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J. Clin. Invest. 99:3018-3024.
66. Xie, J., et al. 1997. Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J. Clin. Endocrinol. Metab. 82:3933-3940.
67. McKenzie, J.M., and Zakarija, M. 1992. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid. 2:155-159.
68. Duprez, L., et al. 1994. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat. Genet. 7:396-401.
69. Kopp, P., et al. 1995. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N. Engl. J. Med. 332:150-154.
70. Tonacchera, M., et al. 1996. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J. Clin. Endocrinol. Metab. 81:547-554.
71. Beamer, W.J., Eicher, E.M., Maltais, L.J., and Southard, J.L. 1981. Inherited primary hypothyroidism in mice. Science. 212:61-63.
72. Stein, S.A., et al. 1994. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol. Endocrinol. 8:129-138.
73. Stein, S.A., et al. 1991. The site of the molecular defect in the thyroid gland of the hyt/hyt mouse: abnormalities in the TSH receptor-G protein complex. Thyroid. 1:257-266.
74. Fernandez Rodriguez, A., et al. 1991. Induction of thyroid proliferative changes in rats treated with antithyroid compound. Anat. Histol. Embryol. 20:289-298.
75. Matsuo, K., Friedman, E., Gejman, P.V., and Fagin, J.A. 1993. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms. J. Clin. Endocrinol. Metab. 76:1446-1451.
76. Krohn, K., and Paschke, R. 2002. Somatic mutations in thyroid nodular disease. Mol. Genet. Metab. 75:202-208.
77. Rodien, P., Ho, S.C., Vlaeminck, V., Vassart, G., and Costagliola, S. 2003. Activating mutations of TSH receptor. Ann. Endocrinol. (Paris). 64:12-16.
78. Krohn, K., Wohlgemuth, S., Gerber, H., and Paschke, R. 2000. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations. J. Pathol. 192:37-42.
79. Tonacchera, M., et al. 2000. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J. Clin. Endocrinol. Metab. 85:2270-2274.
80. Kosugi, S., Ban, T., Akamizu, T., and Kohn, L.D. 1991. Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains. J. Biol. Chem. 266:19413-19418.
81. Costagliola, S., et al. 2002. Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J. 21:504-513.
82. Hershman, J.M. 1999. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors [review]. Thyroid. 9:653-657.
83. Hershman, J.M. 2004. Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 18:249-265.
84. Davies, T., Taliadouros, G., Catt, K., and Nisula, B. 1979. Assessment of urinary thyrotropin-competing activity in choriocarcinoma and thyroid disease: further evidence for human chorionic gonadotropin interacting at the thyroid cell membrane. J. Clin. Endocrinol. Metab. 49:353-357.
85. Davies, T.F., and Platzer, M. 1986. hCG-induced TSH receptor activation and growth acceleration in FRTL-5 thyroid cells. Endocrinology. 118:2149-2151.
86. Tomer, Y., Huber, G.K., and Davies, T.F. 1992. Human chorionic gonadotropin (HCG) interacts directly with recombinant human TSH receptors. J. Clin. Endocrinol. Metab. 74:1477-1479.
87. Glinoer, D., et al. 1990. Regulation of maternal thyroid during pregnancy. J. Clin. Endocrinol. Metab. 71:276-287.
88. Rodien, P., et al. 1998. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N. Engl. J. Med. 339:1823-1826.
89. Smits, G., et al. 2002. Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Mol. Endocrinol. 16:722-735.
90. Rodien, P., et al. 2004. Abnormal stimulation of the thyrotrophin receptor during gestation. Hum. Reprod. Update. 10:95-105.
91. Tsuruta, E., et al. 1995. Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis. J. Clin. Endocrinol. Metab. 80:350-355.
92. Pekary, A.E., et al. 1993. Increased in vitro thyrotropic activity of partially sialated human chorionic gonadotropin extracted from hydatidiform moles of patients with hyperthyroidism. J. Clin. Endocrinol. Metab. 76:70-74.
93. Kraiem, Z., Lahat, N., Sadeh, O., Blithe, D.L., and Nisula, B.C. 1997. Desialylated and deglycosylated human chorionic gonadotropin are superagonists of native human chorionic gonadotropin in human thyroid follicles. Thyroid. 7:783-788.
94. Tomer, Y., and Davies, T.F. 2003. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24:694-717.
95. Bartels, E.D. 1941. Heredity in Graves' disease. Munksgaard. Copenhagen, Denmark. 384 pp.
96. Martin, L. 1945. The heredity and familial aspects of exophthalmic goitre and nodular goitre. Q. J. Med. 14:207-219.
97. Hall, R., and Stanbury, J.B. 1967. Familial studies of autoimmune thyroiditis. Exp. Clin. Endocrinol. 2:719-725.
98. Villanueva, R., Greenberg, D.A., Davies, T.F., and Tomer, Y. 2003. Sibling recurrence risk in autoimmune thyroid disease. Thyroid. 13:761-764.
99. Brix, T.H., Kyvik, K.O., Christensen, K., and Hegedus, L. 2001. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab. 86:930-934.
100. Ringold, D.A., et al. 2002. Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid. 12:647-653.
101. Ban, Y., Greenberg, D.A., Concepcion, E.S., and Tomer, Y. 2002. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid. 12:1079-1083.
102. Ban, Y., et al. 2004. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun. 5:203-208.
103. Chambers, C.A., and Allison, J.P. 1997. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9:396-404.
104. Yanagawa, T., Hidaka, Y., Guimaraes, V., Soliman, M., and DeGroot, L.J. 1995. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. 80:41-45.
105. Kouki, T., et al. 2000. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J. Immunol. 165:6606-6611.
106. Tomer, Y., Greenberg, D.A., Barbesino, G., Concepcion, E., and Davies, T.F. 2001. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J. Clin. Endocrinol. Metab. 86:1687-1693.
107. Ban, Y., and Tomer, Y. 2003. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity. 36:367-379.
108. Ueda, H., et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:506-511.
109. Ban, Y., Tozaki, T., Taniyama, M., and Tomita, M. 2004. Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin. Endocrinol. (Oxf.). 61:263-268.
110. Begovich, A.B., et al. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75:330-337.
111. Bottini, N., et al. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36:337-338.
112. Smyth, D., et al. 2004. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 53:3020-3023.
113. Velaga, M.R., et al. 2004. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J. Clin. Endocrinol. Metab. 89:5862-5865.
114. Tomer, Y., Concepcion, E., and Greenberg, D.A. 2002. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid. 12:1129-1135.
115. Kim, T.Y., et al. 2003. A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid. 13:919-925.
116. Houston, F.A., et al. 2004. Role of the CD40 locus in Graves' disease. Thyroid. 14:506-509.
117. Ban, Y., et al. 2003. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. U.S.A. 100:15119-15124.
118. Collins, J.E., et al. 2003. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 88:5039-5042.
119. Tomer, Y., and Davies, T.F. 1993. Infection, thyroid disease, and autoimmunity. Endocr. Rev. 14:107-120.
120. Bulow Pedersen, I., et al. 2002. Large differences in incidences of over hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J. Clin. Endocrinol. Metab. 87:4462-4469.
121. Prummel, M.F., and Wiersinga, W.M. 1993. Smoking and risk of Graves' disease. JAMA. 269:479-482.
122. Vestergaard, P., et al. 2002. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid. 12:69-75.
123. Santos, A.M., et al. 2002. Grave's disease and stress [abstract]. Acta. Med. Port. 15:423-427.
124. Winsa, B., et al. 1991. Stressful life events and Graves' disease. Lancet. 338:1475-1479.
125. Sonino, N., et al. 1993. Life events in the pathogenesis of Graves' disease. A controlled study. Acta. Endocrinol. (Copenh.). 128:293-296.